Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Faden

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Therapeutics|January 29, 2008
Racial disparities among clinical research investigatorsKenneth Getz, Laura Faden
The Annals of Pharmacotherapy|February 10, 2011
Comment: Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic AgentsLaura Faden, Stephen B Soumerai
Food and Drug Law Journal|December 17, 2009
Off-label use reimbursementJoshua Cohen, Andrew Wilson, Laura Faden
Applied Health Economics and Health Policy|November 30, 2006
Comparing patient access to pharmaceuticals in the UK and USJoshua Cohen, Catherine Cairns, Cherie Paquette, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Are Medicare plans complying with CMS regulation?Joshua Cohen, Brian Young, Stephanie Rochon, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2007
Patient access to pharmaceuticals: an international comparisonJoshua Cohen, Laura Faden, Susan Predaris, et al.
Southern Med Review|March 29, 2013
Improving access to medicines in low and middle income countries: corporate responsibilities in contextKlaus Michael Leisinger, Laura Faden Garabedian, Anita Katharina Wagner
Annals of Internal Medicine|December 2, 2014
Instrumental variable analyses for observational comparative effectiveness research: the paired availability designLaura Faden Garabedian, Alan M Zaslavsky, Stephen B Soumerai
Health Policy (Amsterdam, Netherlands)|December 28, 2010
Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidenceLaura Faden, Catherine Vialle-Valentin, Dennis Ross-Degnan, et al.
BMJ Open|November 30, 2012
Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series studyLaura Faden Garabedian, Dennis Ross-Degnan, Sauwakon Ratanawijitrasin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Therapeutics|January 29, 2008
Racial disparities among clinical research investigatorsKenneth Getz, Laura Faden
The Annals of Pharmacotherapy|February 10, 2011
Comment: Assessment of Changes in Utilization of Health-Care Services After Implementation of a Prior Authorization Policy for Atypical Antipsychotic AgentsLaura Faden, Stephen B Soumerai
Food and Drug Law Journal|December 17, 2009
Off-label use reimbursementJoshua Cohen, Andrew Wilson, Laura Faden
Applied Health Economics and Health Policy|November 30, 2006
Comparing patient access to pharmaceuticals in the UK and USJoshua Cohen, Catherine Cairns, Cherie Paquette, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Are Medicare plans complying with CMS regulation?Joshua Cohen, Brian Young, Stephanie Rochon, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2007
Patient access to pharmaceuticals: an international comparisonJoshua Cohen, Laura Faden, Susan Predaris, et al.
Southern Med Review|March 29, 2013
Improving access to medicines in low and middle income countries: corporate responsibilities in contextKlaus Michael Leisinger, Laura Faden Garabedian, Anita Katharina Wagner
Annals of Internal Medicine|December 2, 2014
Instrumental variable analyses for observational comparative effectiveness research: the paired availability designLaura Faden Garabedian, Alan M Zaslavsky, Stephen B Soumerai
Health Policy (Amsterdam, Netherlands)|December 28, 2010
Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidenceLaura Faden, Catherine Vialle-Valentin, Dennis Ross-Degnan, et al.
BMJ Open|November 30, 2012
Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series studyLaura Faden Garabedian, Dennis Ross-Degnan, Sauwakon Ratanawijitrasin, et al.
Pageof 2